Leave a Comment / Tobacco Smoke Control / By

Tobacco Smoke Control ?

Tobacco smoke control refers to policies and practices aimed at reducing the harmful effects of tobacco smoke, particularly secondhand smoke. These measures are crucial for protecting public health, as tobacco smoke contains numerous toxins and carcinogens that can cause serious illnesses, including cancer, heart disease, and respiratory problems.

Here are some key aspects of tobacco smoke control:

  • Smoke-free environments: Implementing laws and policies that prohibit smoking in public places, workplaces, and other shared spaces is a cornerstone of tobacco smoke control. These measures protect non-smokers from involuntary exposure to secondhand smoke.
  • Education and awareness: Public health campaigns play a vital role in educating people about the dangers of tobacco smoke and promoting smoke-free lifestyles. These initiatives can help to change social norms around smoking and encourage smokers to quit.
  • Cessation support: Providing accessible and affordable resources to help smokers quit is essential. This includes offering counseling services, nicotine replacement therapy, and other evidence-based interventions.
  • Regulation of tobacco products: Governments can regulate the manufacturing, marketing, and sale of tobacco products to make them less appealing and accessible, particularly to young people. This may include measures such as plain packaging, restrictions on advertising, and increased taxation.

The World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC) is an international treaty that provides a framework for countries to implement comprehensive tobacco control measures. The FCTC outlines various strategies, including those mentioned above, to reduce tobacco use and exposure to tobacco smoke.

What is Tobacco Smoke Control ?

This is for informational purposes only. For medical advice or diagnosis, consult a professional.

Tobacco smoke control is a set of strategies and policies aimed at reducing the harmful effects of tobacco smoke, particularly secondhand smoke. These measures are essential for protecting public health, as tobacco smoke contains numerous toxins and carcinogens that can cause serious illnesses, including cancer, heart disease, and respiratory problems.

Here are some key aspects of tobacco smoke control:

  • Smoke-free environments: Implementing laws and policies that prohibit smoking in public places, workplaces, and other shared spaces is a cornerstone of tobacco smoke control. These measures protect non-smokers from involuntary exposure to secondhand smoke.
  • Education and awareness: Public health campaigns play a vital role in educating people about the dangers of tobacco smoke and promoting smoke-free lifestyles. These initiatives can help to change social norms around smoking and encourage smokers to quit.
  • Cessation support: Providing accessible and affordable resources to help smokers quit is essential. This includes offering counseling services, nicotine replacement therapy, and other evidence-based interventions.
  • Regulation of tobacco products: Governments can regulate the manufacturing, marketing, and sale of tobacco products to make them less appealing and accessible, particularly to young people. This may include measures such as plain packaging, restrictions on advertising, and increased taxation.

The World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC) is an international treaty that provides a framework for countries to implement comprehensive tobacco control measures. The FCTC outlines various strategies, including those mentioned above, to reduce tobacco use and exposure to tobacco smoke.

Who is required Tobacco Smoke Control ?

This is for informational purposes only. For medical advice or diagnosis, consult a professional.

Tobacco smoke control is essential for protecting the health of everyone, but some groups are particularly vulnerable to the harmful effects of secondhand smoke. These include:

  • Children: Children are especially susceptible to the dangers of secondhand smoke because their lungs are still developing. Exposure to secondhand smoke increases their risk of asthma, respiratory infections, ear infections, and sudden infant death syndrome (SIDS).
  • Pregnant women: Smoking during pregnancy can lead to serious complications, such as premature birth, low birth weight, and birth defects. Secondhand smoke exposure is also harmful to pregnant women and their babies.
  • People with respiratory conditions: Individuals with asthma, chronic obstructive pulmonary disease (COPD), or other respiratory illnesses are more sensitive to the irritants in tobacco smoke. Exposure can trigger symptoms and worsen their condition.
  • Older adults: Older adults are more vulnerable to the health effects of secondhand smoke due to age-related changes in their bodies. It can increase their risk of heart disease, stroke, and lung cancer.

In addition to these vulnerable groups, tobacco smoke control is also important for:

  • Smokers: Implementing smoke-free policies can create a supportive environment for smokers who are trying to quit. It can also help to reduce their exposure to the harmful chemicals in tobacco smoke.
  • Non-smokers: Everyone has the right to breathe clean air, free from the dangers of secondhand smoke. Smoke-free environments protect non-smokers from involuntary exposure to harmful toxins.

Overall, tobacco smoke control is a crucial public health issue that affects everyone. By implementing comprehensive measures, we can create a healthier and safer environment for all.

When is required Tobacco Smoke Control ?

This is for informational purposes only. For medical advice or diagnosis, consult a professional.

Tobacco smoke control is always necessary to protect people from the harmful effects of secondhand smoke. There is no specific time when it is more or less important. However, there are certain situations where tobacco smoke control is particularly crucial:

  • Public places: Smoke-free laws and policies are essential in public places such as restaurants, bars, shopping malls, and transportation facilities. These measures protect non-smokers from involuntary exposure to secondhand smoke and create a healthier environment for everyone.
  • Workplaces: Implementing smoke-free policies in workplaces is crucial for protecting the health of employees. Secondhand smoke can cause serious health problems, and workers have the right to a safe and healthy work environment.
  • Homes: Creating smoke-free homes is essential for protecting children and other family members from the dangers of secondhand smoke. Children are particularly vulnerable to the harmful effects of tobacco smoke, and parents have a responsibility to create a smoke-free environment for their children.
  • Vehicles: Smoking in cars, especially when children are present, is extremely dangerous. Smoke-free policies in vehicles can help to protect children and other passengers from the harmful effects of secondhand smoke.
  • Events: Smoke-free policies at public events, such as concerts, festivals, and sporting events, can help to create a healthier environment for attendees.

In addition to these situations, tobacco smoke control is also important in communities with high smoking rates or among vulnerable populations, such as pregnant women, people with respiratory conditions, and older adults. By implementing comprehensive tobacco control measures, we can create a healthier and safer environment for everyone.

COURTESY : Sahyadri Hospitals

Where is required Tobacco Smoke Control ?

This is for informational purposes only. For medical advice or diagnosis, consult a professional.

Tobacco smoke control is required in any place where people can be exposed to secondhand smoke. This includes:

  • Public places: Restaurants, bars, shopping malls, transportation facilities, and other shared spaces should be smoke-free to protect non-smokers from involuntary exposure to harmful toxins.
  • Workplaces: Employees have the right to a safe and healthy work environment, free from the dangers of secondhand smoke. Smoke-free policies in workplaces are essential for protecting their health.
  • Homes: Children and other family members should be protected from the harmful effects of secondhand smoke in their own homes. Creating smoke-free homes is crucial for safeguarding their health.
  • Vehicles: Smoking in cars, especially when children are present, is extremely dangerous. Smoke-free policies in vehicles can help to protect passengers from the harmful effects of secondhand smoke.
  • Events: Public events such as concerts, festivals, and sporting events should be smoke-free to create a healthier environment for attendees.
  • Communities: Tobacco smoke control is also important in communities with high smoking rates or among vulnerable populations, such as pregnant women, people with respiratory conditions, and older adults.

By implementing comprehensive tobacco control measures in all of these settings, we can create a healthier and safer environment for everyone.

How is required Tobacco Smoke Control ?

This is for informational purposes only. For medical advice or diagnosis, consult a professional.

Tobacco smoke control can be implemented through a variety of strategies and policies. Here are some key approaches:

  • Legislation and regulation: Governments can enact laws and regulations to restrict or ban smoking in public places, workplaces, and other shared spaces. These measures can also include restrictions on tobacco advertising, promotion, and sponsorship, as well as mandatory health warnings on tobacco packaging.
  • Taxation: Increasing taxes on tobacco products can make them less affordable, particularly for young people and low-income individuals. This can discourage tobacco use and encourage smokers to quit.
  • Education and awareness campaigns: Public health campaigns can play a vital role in educating people about the dangers of tobacco smoke and promoting smoke-free lifestyles. These initiatives can help to change social norms around smoking and encourage smokers to quit.
  • Cessation support: Providing accessible and affordable resources to help smokers quit is essential. This includes offering counseling services, nicotine replacement therapy, and other evidence-based interventions.
  • Smoke-free environments: Creating smoke-free environments in public places, workplaces, homes, and vehicles is crucial for protecting people from the harmful effects of secondhand smoke. This can be achieved through policies, regulations, and voluntary initiatives.

The World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC) provides a comprehensive framework for countries to implement these and other tobacco control measures. The FCTC outlines various strategies to reduce tobacco use and exposure to tobacco smoke, including:

  • Protecting people from tobacco smoke
  • Helping tobacco users to quit
  • Warning about the dangers of tobacco
  • Enforcing bans on tobacco advertising, promotion, and sponsorship
  • Raising taxes on tobacco  

By implementing these comprehensive strategies, governments and communities can effectively reduce the harms of tobacco smoke and create a healthier environment for everyone.

Case study is Tobacco Smoke Control ?

This is for informational purposes only. For medical advice or diagnosis, consult a professional.

Absolutely! Here’s a case study on tobacco smoke control, focusing on a specific region or policy:

Case Study: Ireland’s Smoke-Free Workplace Legislation

Background

  • Ireland was one of the first countries in the world to implement a nationwide ban on smoking in all workplaces, including bars and restaurants, in 2004.
  • This legislation was a significant step in protecting public health and reducing exposure to secondhand smoke.

Implementation

  • The Irish government introduced the Public Health (Tobacco) Act, 2002, which made it illegal to smoke in enclosed workplaces.
  • The legislation was accompanied by public awareness campaigns to educate people about the dangers of secondhand smoke and the benefits of a smoke-free environment.
  • Enforcement of the ban was carried out through inspections and penalties for non-compliance.

Outcomes

  • Improved public health: Studies have shown a significant decrease in exposure to secondhand smoke in workplaces, leading to improvements in respiratory health and a reduction in heart disease risk.
  • Increased support for smoke-free policies: The legislation has been widely accepted by the public, with high levels of compliance and support for smoke-free environments.
  • Reduced smoking prevalence: The ban has been associated with a decrease in smoking rates, as it has created a more supportive environment for smokers who want to quit.
  • Economic impact: Contrary to initial concerns, the smoke-free legislation has not had a negative impact on the hospitality industry. In fact, some studies suggest that it may have even had a positive effect.

Lessons Learned

  • Strong political will: The success of Ireland’s smoke-free legislation was due in part to strong political leadership and commitment to public health.
  • Public support: Public awareness campaigns and engagement helped to build support for the legislation and ensure its successful implementation.
  • Enforcement: Effective enforcement mechanisms were crucial for ensuring compliance with the ban.
  • Evaluation: Ongoing evaluation of the impact of the legislation is important for assessing its effectiveness and making any necessary adjustments.

Conclusion

Ireland’s smoke-free workplace legislation is a successful example of how comprehensive tobacco control measures can protect public health and reduce the harms of secondhand smoke. It demonstrates the importance of strong political will, public support, and effective enforcement in achieving positive outcomes. This case study can serve as a model for other countries seeking to implement similar policies.

COURTESY : Joseph R Nemeth DDS

White paper on Tobacco Smoke Control ?

White Paper: Tobacco Smoke Control – A Global Imperative

Executive Summary:

Tobacco use remains a leading cause of preventable death and disease worldwide. Secondhand smoke, also known as environmental tobacco smoke, poses a significant health risk to non-smokers, contributing to a range of serious illnesses. This white paper examines the compelling need for comprehensive tobacco smoke control strategies, outlining the health impacts of secondhand smoke, summarizing effective interventions, and advocating for strengthened policies to protect public health.

1. The Devastating Impact of Secondhand Smoke:

Secondhand smoke is a complex mixture of gases and fine particles containing numerous toxins and carcinogens. Exposure to secondhand smoke increases the risk of:

  • Cancer: Particularly lung cancer, even in non-smokers.
  • Cardiovascular Diseases: Including heart disease, stroke, and increased risk of heart attacks.
  • Respiratory Problems: Such as asthma, chronic obstructive pulmonary disease (COPD), and respiratory infections, especially in children.
  • Sudden Infant Death Syndrome (SIDS): Infants exposed to secondhand smoke are at increased risk.
  • Developmental Issues: Children exposed to secondhand smoke during pregnancy or childhood may experience impaired lung development and other health problems.

The burden of these diseases translates to significant healthcare costs, lost productivity, and diminished quality of life.

2. Effective Tobacco Smoke Control Strategies:

A multi-faceted approach is essential for effective tobacco smoke control. Key strategies include:

  • Smoke-Free Environments: Implementing comprehensive smoke-free laws in all public places, including workplaces, restaurants, bars, and transportation facilities, is crucial. These laws protect non-smokers from involuntary exposure to secondhand smoke and create a supportive environment for smokers who wish to quit.
  • Public Awareness Campaigns: Educating the public about the dangers of secondhand smoke through mass media campaigns, community outreach programs, and educational materials is vital. These campaigns should aim to change social norms surrounding smoking and promote smoke-free lifestyles.
  • Cessation Support: Providing accessible and affordable smoking cessation services, including counseling, nicotine replacement therapy, and other evidence-based interventions, is essential to help smokers quit.
  • Tobacco Product Regulation: Implementing policies to regulate the manufacturing, marketing, and sale of tobacco products is crucial. This includes measures such as plain packaging, restrictions on advertising and promotion, and increased taxation.
  • Enforcement and Monitoring: Strong enforcement mechanisms are necessary to ensure compliance with smoke-free laws and regulations. Continuous monitoring of tobacco use and exposure to secondhand smoke is essential to evaluate the effectiveness of control measures.

3. The Role of Policy and Legislation:

Strong political will and effective legislation are fundamental to successful tobacco smoke control. Governments should:

  • Ratify and implement the WHO Framework Convention on Tobacco Control (FCTC): The FCTC provides a comprehensive framework for countries to implement evidence-based tobacco control measures.
  • Enact and enforce comprehensive smoke-free laws: These laws should cover all public places and workplaces, without exceptions.
  • Invest in public health infrastructure: Adequate resources are needed to support public awareness campaigns, cessation services, and enforcement efforts.
  • Collaborate with stakeholders: Engaging with healthcare professionals, non-governmental organizations, and other stakeholders is essential to develop and implement effective tobacco control strategies.

4. Addressing Disparities:

Tobacco use and exposure to secondhand smoke disproportionately affect certain populations, including low-income communities, indigenous populations, and certain occupational groups. Targeted interventions are needed to address these disparities and ensure that all populations are protected.

5. Conclusion and Recommendations:

Tobacco smoke control is a critical public health imperative. The evidence is clear: secondhand smoke causes serious harm. Governments, public health organizations, and individuals must work together to implement comprehensive tobacco control strategies to protect current and future generations from the devastating consequences of tobacco use and exposure to secondhand smoke. We recommend:

  • Prioritizing tobacco smoke control as a public health priority.
  • Strengthening political commitment and increasing resources for tobacco control.
  • Implementing comprehensive smoke-free laws in all public places and workplaces.
  • Expanding access to smoking cessation services.
  • Strengthening tobacco product regulation.
  • Addressing disparities in tobacco use and exposure.

By taking decisive action, we can create a world where everyone can breathe clean air, free from the dangers of tobacco smoke.

Industrial application of Tobacco Smoke Control ?

This is for informational purposes only. For medical advice or diagnosis, consult a professional.

While the primary focus of tobacco smoke control is on public health, there are some industrial applications that indirectly relate to these efforts:

  • Manufacturing of smoking cessation products: The pharmaceutical industry plays a crucial role in developing and manufacturing nicotine replacement therapies (NRTs) like patches, gum, and lozenges, as well as other medications that help smokers quit. These products are essential tools in tobacco control efforts.
  • Production of smoke-free alternatives: Some industries are involved in the development and manufacturing of alternative nicotine products, such as e-cigarettes and heated tobacco products. While the health impacts of these products are still being studied, they are often considered as potentially less harmful alternatives to traditional cigarettes.
  • Development of air filtration technologies: Industries that specialize in air filtration and ventilation systems can contribute to tobacco smoke control by developing technologies that effectively remove secondhand smoke from indoor environments. These technologies can be used in public places, workplaces, and even homes to reduce exposure to harmful toxins.
  • Research and development: Various industries, including those in the fields of science, technology, and healthcare, contribute to tobacco smoke control through research and development efforts. This includes studying the health effects of tobacco smoke, developing new cessation interventions, and evaluating the effectiveness of different control measures.

It’s important to note that while these industrial applications can play a role in tobacco smoke control, the primary focus remains on public health and reducing the harms of tobacco use. The most effective strategies involve comprehensive approaches that combine legislation, education, cessation support, and regulation to create a smoke-free environment for everyone.

Research and development of Tobacco Smoke Control ?

This is for informational purposes only. For medical advice or diagnosis, consult a professional.

Absolutely! Research and development play a crucial role in advancing tobacco smoke control efforts. Here are some key areas where R&D is making a difference:

  • Understanding the health effects of tobacco smoke: Researchers continue to investigate the complex mechanisms by which tobacco smoke causes harm. This includes studying the specific toxins and carcinogens in tobacco smoke, their impact on various organs and systems, and the long-term health consequences of exposure.
  • Developing effective cessation interventions: R&D efforts focus on creating and improving interventions to help smokers quit. This includes pharmacological approaches, such as new medications to reduce cravings and withdrawal symptoms, as well as behavioral interventions, such as counseling and support programs.
  • Evaluating smoke-free alternatives: Researchers are studying the potential risks and benefits of alternative nicotine products, such as e-cigarettes and heated tobacco products. This includes assessing their impact on smoking cessation, their long-term health effects, and their role in tobacco control strategies.
  • Improving air filtration technologies: R&D in this area aims to develop more effective air filtration and ventilation systems that can remove secondhand smoke from indoor environments. This includes exploring new materials and technologies that can capture and neutralize harmful toxins in tobacco smoke.
  • Studying the impact of policies and regulations: Researchers evaluate the effectiveness of various tobacco control policies and regulations, such as smoke-free laws, tobacco taxes, and advertising restrictions. This helps to inform policymakers and guide the development of evidence-based strategies.
  • Addressing disparities in tobacco use: R&D efforts also focus on understanding and addressing disparities in tobacco use among different populations. This includes studying the social, economic, and cultural factors that contribute to these disparities and developing targeted interventions to reduce tobacco use in vulnerable groups.

Through ongoing research and development, we can continue to make progress in tobacco smoke control and protect public health from the harmful effects of tobacco smoke.

COURTESY : Ministry of Health & Family Welfare

References

  1. ^ Jump up to:a b Gately, Iain (2004) [2003]. Tobacco: A Cultural History of How an Exotic Plant Seduced Civilization. Diane. pp. 3–7. ISBN 978-0-8021-3960-3. Archived from the original on 14 January 2023. Retrieved 22 March 2009.
  2. ^ Jump up to:a b c Lloyd, John; Mitchinson, John (25 July 2008). The Book of General Ignorance. Harmony Books. ISBN 978-0-307-39491-0.
  3. ^ West, Robert; Shiffman, Saul (2007). Fast Facts: Smoking Cessation. Health Press Ltd. p. 28. ISBN 978-1-903734-98-8.
  4. ^ Jump up to:a b c Wigand, Jeffrey S. (July 2006). “ADDITIVES, CIGARETTE DESIGN and TOBACCO PRODUCT REGULATION” (PDF). Mt. Pleasant, MI 48804: Jeffrey Wigand. Archived (PDF) from the original on 16 May 2011. Retrieved 14 February 2009.
  5. ^ Jump up to:a b Gilman & Xun 2004, p. 318
  6. ^ Jump up to:a b Parrott, A. C.; Winder, G. (1989). “Nicotine chewing gum (2 mg, 4 mg) and cigarette smoking: comparative effects upon vigilance and heart rate”. Psychopharmacology. 97 (2): 257–261. doi:10.1007/BF00442260. PMID 2498936. S2CID 4842374.
  7. ^ Jump up to:a b Parkin, C.; Fairweather, D. B.; Shamsi, Z.; Stanley, N.; Hindmarch, I. (1998). “The effects of cigarette smoking on overnight performance”. Psychopharmacology. 136 (2): 172–178. doi:10.1007/s002130050553. PMID 9551774. S2CID 22962937.
  8. ^ Gilman & Xun 2004, pp. 320–321
  9. ^ Benowitz, Neal L. (1 February 2009). “Pharmacology of Nicotine: Addiction, Smoking-Induced Disease, and Therapeutics”. Annual Review of Pharmacology and Toxicology. 49 (1): 57–71. doi:10.1146/annurev.pharmtox.48.113006.094742. ISSN 0362-1642. PMC 2946180. PMID 18834313.
  10. ^ Jump up to:a b c Proctor 2000, p. 228
  11. ^ Jump up to:a b Doll, R.; Hill, B. (June 2004). “The mortality of doctors in relation to their smoking habits: a preliminary report: (Reprinted from Br Med J 1954:ii;1451-5)”. BMJ (Clinical Research Ed.). 328 (7455): 1529–1533, discussion 1533. doi:10.1136/bmj.328.7455.1529. ISSN 0959-8138. PMC 437141. PMID 15217868.
  12. ^ Jump up to:a b VJ Rock, MPH, A Malarcher, JW Kahende, K Asman, MSPH, C Husten, MD, R Caraballo (9 November 2007). “Cigarette Smoking Among Adults — United States, 2006”. United States Centers for Disease Control and Prevention. Archived from the original on 16 August 2019. Retrieved 1 January 2009. In 2006, an estimated 20.8% (45.3 million) of U.S. adults[…]
  13. ^ Jump up to:a b c d “WHO/WPRO-Smoking Statistics”. World Health Organization Regional Office for the Western Pacific. 28 May 2002. Archived from the original on 8 November 2009. Retrieved 1 January 2009.
  14. ^ Giovino, GA; Mirza, SA; Samet, JM; Gupta, PC; Jarvis, MJ; Bhala, N; Peto, R; Zatonski, W; Hsia, J; Morton, J; Palipudi, KM; Asma, S; GATS Collaborative, Group (18 August 2012). “Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys”. Lancet. 380 (9842): 668–79. doi:10.1016/S0140-6736(12)61085-X. ISSN 0140-6736. PMID 22901888. S2CID 12450625.
  15. ^ Jump up to:a b The World Health Organization, and the Institute for Global Tobacco Control, Johns Hopkins School of Public Health (2001). “Women and the Tobacco Epidemic: Challenges for the 21st Century” (PDF). World Health Organization. pp. 5–6. Archived from the original (PDF) on 28 November 2003. Retrieved 2 January 2009.
  16. ^ Jump up to:a b “Surgeon General’s Report—Women and Smoking”. Centers for Disease Control and Prevention. 2001. p. 47. Archived from the original on 10 July 2009. Retrieved 3 January 2009.
  17. ^ Jump up to:a b c d “Tobacco”. www.who.int. Retrieved 24 February 2024.
  18. ^ Jump up to:a b c d e Chandrupatla, Siddardha G.; Tavares, Mary; Natto, Zuhair S. (27 July 2017). “Tobacco Use and Effects of Professional Advice on Smoking Cessation among Youth in India”. Asian Pacific Journal of Cancer Prevention. 18 (7): 1861–1867. doi:10.22034/APJCP.2017.18.7.1861. ISSN 2476-762X. PMC 5648391. PMID 28749122.
  19. ^ The Lancet (26 September 2009). “Tobacco smoking:why start?”. The Lancet. 374 (9695): 1038. doi:10.1016/s0140-6736(09)61680-9. PMID 19782852. S2CID 37513171.
  20. ^ Nuwer, Rachel (11 October 2021). Stix, Gary (ed.). “Mammoths Roamed when Humans Started Using Tobacco at Least 12,300 Years Ago”. Scientific American. Springer Nature. Retrieved 16 February 2025. […] researchers […] identified the charred remnants of four tobacco seeds. Radiocarbon dating of willow wood charcoal also recovered from the hearth revealed that the entire contents, including the seeds, were approximately 12,300 years old. […] [Daron] Duke and his colleagues do not know in what manner the tobacco was used, but they believe it could have been smoked or put behind the lip and sucked.
  21. ^ Wilbert, Johannes (28 July 1993). Tobacco and Shamanism in South America. Yale University Press. ISBN 978-0-300-05790-4. Archived from the original on 14 January 2023. Retrieved 22 March 2009.
  22. ^ Robicsek, Francis (January 1979). The Smoking Gods: Tobacco in Maya Art, History, and Religion. University of Oklahoma Press. p. 30. ISBN 978-0-8061-1511-5.
  23. ^ F.J.Carod-Artal (1 July 2011). “Hallucinogenic drugs in pre-Columbian Mesoamerican cultures”. Neurología. 30 (1): 42–49. doi:10.1016/j.nrleng.2011.07.010. PMID 21893367.
  24. ^ Nordenskiold, Erland (1929), “The American Indian as an Inventor”, Journal of the Royal Anthropological Institute, 59: 277, doi:10.2307/2843888, JSTOR 2843888
  25. ^ Heckewelder, John Gottlieb Ernestus; Reichel, William Cornelius (June 1971) [1876]. History, manners, and customs of the Indian nations who once inhabited Pennsylvania and the neighboring states (PDF). The Historical Society of Pennsylvania. p. 149. ISBN 978-0-405-02853-3. Archived from the original on 14 January 2023. Retrieved 22 March 2009.
  26. ^ Diéreville; Webster, John Clarence; Webster, Alice de Kessler Lusk (1933). Relation of the voyage to Port Royal in Acadia or New France. The Champlain Society. They smoke with excessive eagerness […] men, women, girls and boys, all find their keenest pleasure in this way
  27. ^ Gottsegen, Jack Jacob (1940). Tobacco: A Study of Its Consumption in the United States. Pitman Publishing Company. p. 107. Archived from the original on 14 January 2023. Retrieved 22 March 2009. Smoke also provided another means of communication to the Great Spirit.
  28. ^ Balls, Edward K. (1 October 1962). Early Uses of California Plants. University of California Press. pp. 81–85. ISBN 978-0-520-00072-8. Retrieved 22 March 2009. Early Uses of California Plants.
  29. ^ Jordan, Ervin L. Jr. “Jamestown, Virginia, 1607–1907: An Overview”. University of Virginia. Archived from the original on 17 October 2002. Retrieved 22 February 2009. {{cite journal}}: Cite journal requires |journal= (help)
  30. ^ Kulikoff, Allan (1 August 1986). Tobacco and Slaves: The Development of Southern Cultures in the Chesapeake. The University of North Carolina Press. ISBN 978-0-8078-4224-9. Retrieved 22 March 2009. Tobacco & Slaves: The Development of Southern Cultures in the Chesapeake.
  31. ^ Gilman & Xun 2004, p. 38
  32. ^ Gilman & Xun 2004, pp. 92–99
  33. ^ Gilman & Xun 2004, pp. 15–16
  34. ^ King James I of England (16 April 2002) [1604]. “A Counterblaste to Tobacco”. University of Texas at Austin. Archived from the original on 18 May 2009. Retrieved 22 March 2009. {{cite journal}}: Cite journal requires |journal= (help)
  35. ^ Burns, Eric (28 September 2006). The Smoke of the Gods: A Social History of Tobacco. Temple University Press. pp. 134–135. ISBN 978-1-59213-480-9. Archived from the original on 14 January 2023. Retrieved 22 March 2009.
  36. ^ Proctor 2000, p. 178
  37. ^ Proctor 2000, p. 219
  38. ^ Proctor 2000, p. 187
  39. ^ Jump up to:a b Proctor 2000, p. 245
  40. ^ Proctor, Robert N. (1996). “Nazi Medicine and Public Health Policy”. Dimensions. 10 (2). Anti-Defamation League. Archived from the original on 5 December 2012. Retrieved 1 October 2018 – via archived copy at archive.is.
  41. ^ Doll, R.; Hill, A. B. (1 September 1950). “Smoking and Carcinoma of the Lung”. British Medical Journal. 2 (4682): 739–748. doi:10.1136/bmj.2.4682.739. ISSN 0007-1447. PMC 2038856. PMID 14772469.
  42. ^ “CNN Interactive”. Cnn.com. Archived from the original on 23 April 2009. Retrieved 22 June 2009.
  43. ^ “The Reports of the Surgeon General: The 1964 Report on Smoking and Health”. Profiles in Science. United States National Library of Medicine, National Institutes of Health. Archived from the original on 20 January 2016. Retrieved 10 October 2015.
  44. ^ Milo Geyelin (23 November 1998). “Forty-Six States Agree to Accept $206 Billion Tobacco Settlement”. Wall Street Journal.
  45. ^ Hilton, Matthew (4 May 2000). Smoking in British Popular Culture, 1800–2000: Perfect Pleasures. Manchester University Press. pp. 229–241. ISBN 978-0-7190-5257-6. Archived from the original on 14 January 2023. Retrieved 22 March 2009.
  46. ^ Gilman & Xun 2004, pp. 46–57
  47. ^ Jump up to:a b MPOWER 2008, pp. 267–288
  48. ^ “Bidi Use Among Urban Youth – Massachusetts, March–April 1999”. Centers for Disease Control and Prevention. 17 September 1999. Archived from the original on 11 February 2009. Retrieved 14 February 2009.
  49. ^ Pakhale, S. M.; Maru, G. B. (December 1998). “Distribution of major and minor alkaloids in tobacco, mainstream and sidestream smoke of popular Indian smoking products”. Food and Chemical Toxicology. 36 (12): 1131–1138. doi:10.1016/S0278-6915(98)00071-4. ISSN 0278-6915. PMID 9862656.
  50. ^ Rarick CA (2 April 2008). “Note on the premium cigar industry”. doi:10.2139/ssrn.1127582. S2CID 152340055. SSRN 1127582. {{cite journal}}: Cite journal requires |journal= (help)
  51. ^ Mariolis P, Rock VJ, Asman K, et al. (2006). “Tobacco use among adults—United States, 2005”. MMWR Morb Mortal Wkly Rep. 55 (42): 1145–8. PMID 17065979. Archived from the original on 26 September 2017. Retrieved 17 September 2017.
  52. ^ “A bill to protect the public health by providing the Food and Drug Administration with certain authority to regulate tobacco products. (Summary)” (Press release). Library of Congress. 20 May 2004. Archived from the original on 4 September 2015. Retrieved 1 August 2007.
  53. ^ Turner, JA; Sillett, RW; McNicol, MW (1977). “Effect of cigar smoking on carboxyhemoglobin and plasma nicotine concentrations in primary pipe and cigar smokers and ex-cigarette smokers”. British Medical Journal. 2 (6099): 1387–9. doi:10.1136/bmj.2.6099.1387. PMC 1632361. PMID 589225.
  54. ^ Armitage, A. K.; Turner, D. M. (1970). “Absorption of Nicotine in Cigarette and Cigar Smoke through the Oral Mucosa”. Nature. 226 (5252): 1231–1232. Bibcode:1970Natur.226.1231A. doi:10.1038/2261231a0. PMID 5422597. S2CID 4208650.
  55. ^ Pich, E. M.; Pagliusi, S. R.; Tessari, M.; Talabot-Ayer, D.; Hooft Van Huijsduijnen, R.; Chiamulera, C. (1997). “Common neural substrates for the addictive properties of nicotine and cocaine”. Science. 275 (5296): 83–86. doi:10.1126/science.275.5296.83. PMID 8974398. S2CID 5923174.
  56. ^ Wonnacott, S. (1997). “Presynaptic nicotinic ACh receptors”. Trends in Neurosciences. 20 (2): 92–8. doi:10.1016/S0166-2236(96)10073-4. PMID 9023878. S2CID 42215860.
  57. ^ Pontieri, F. E.; Tanda, G.; Orzi, F.; Di Chiara, G. D. (1996). “Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs”. Nature. 382 (6588): 255–257. Bibcode:1996Natur.382..255P. doi:10.1038/382255a0. PMID 8717040. S2CID 4338516.
  58. ^ Guinan, M. E.; Portas, M. R.; Hill, H. R. (1979). “The candida precipitin test in an immunosuppressed population”. Cancer. 43 (1): 299–302. doi:10.1002/1097-0142(197901)43:1<299::AID-CNCR2820430143>3.0.CO;2-D. PMID 761168. S2CID 45096870.
  59. ^ Talhout, R.; Opperhuizen, A.; Van Amsterdam, J. G. C. (October 2007). “Role of acetaldehyde in tobacco smoke addiction”. European Neuropsychopharmacology. 17 (10): 627–636. doi:10.1016/j.euroneuro.2007.02.013. ISSN 0924-977X. PMID 17382522. S2CID 25866206.
  60. ^ Shoaib, M.; Lowe, A.; Williams, S. (2004). “Imaging localised dynamic changes in the nucleus accumbens following nicotine withdrawal in rats”. NeuroImage. 22 (2): 847–854. doi:10.1016/j.neuroimage.2004.01.026. PMID 15193614. S2CID 43544025.
  61. ^ Jump up to:a b Guindon, G. Emmanuel; Boisclair, David (2003). “Past, current and future trends in tobacco use” (PDF). Washington DC: The International Bank for Reconstruction and Development / The World Bank: 13–16. Archived from the original (PDF) on 18 March 2009. Retrieved 22 March 2009. {{cite journal}}: Cite journal requires |journal= (help)
  62. ^ Peto, Richard; Lopez, Alan D; Boreham, Jillian; Thun, Michael (2006). “Mortality from Smoking in Developed Countries 1950–2000: indirect estimates from national vital statistics” (PDF). Oxford University Press: 9. Archived from the original (PDF) on 24 February 2005. Retrieved 22 March 2009. {{cite journal}}: Cite journal requires |journal= (help)
  63. ^ Tobaccofreekids.org/problem/tol-s
  64. ^ Centers for Disease Control and Prevention (CDC) (2009). “Cigarette smoking among adults and trends in smoking cessation – United States, 2008” (Full free text). MMWR. Morbidity and Mortality Weekly Report. 58 (44): 1227–1232. PMID 19910909. Archived from the original on 16 September 2017. Retrieved 17 September 2017.
  65. ^ GBD 2008, p. 8
  66. ^ GBD 2008, p. 23
  67. ^ Jump up to:a b “WHO/WPRO-Tobacco Fact sheet”. World Health Organization Regional Office for the Western Pacific. 29 May 2007. Archived from the original on 7 February 2009. Retrieved 1 January 2009.
  68. ^ “Smoking causes one in 10 deaths worldwide, study shows”. BBC News. 6 April 2017. Archived from the original on 10 April 2017. Retrieved 11 April 2017.
  69. ^ Gay, Peter (1988). Freud: A Life for Our Time. New York: W. W. Norton & Company. pp. 650–651. ISBN 978-0-393-32861-5.
  70. ^ Patton G. C.; Hibbert M.; Rosier M. J.; Carlin J. B.; Caust J.; Bowes G. (1996). “Is smoking associated with depression and anxiety in teenagers?”. American Journal of Public Health. 86 (2): 225–230. doi:10.2105/ajph.86.2.225. PMC 1380332. PMID 8633740.
  71. ^ Stanton, W.; Silva, P. A. (1992). “A longitudinal study of the influence of parents and friends on children’s initiation of smoking”. Journal of Applied Developmental Psychology. 13 (4): 423–434. doi:10.1016/0193-3973(92)90010-F.
  72. ^ Harris, Judith Rich; Pinker, Steven (4 September 1998). The nurture assumption: why children turn out the way they do. Simon and Schuster. ISBN 978-0-684-84409-1. Archived from the original on 14 January 2023. Retrieved 22 March 2009.
  73. ^ Chassin, L.; Presson, C.; Rose, J.; Sherman, S. J.; Prost, J. (2002). “Parental Smoking Cessation and Adolescent Smoking”. Journal of Pediatric Psychology. 27 (6): 485–496. doi:10.1093/jpepsy/27.6.485. PMID 12177249.
  74. ^ Proescholdbell, R. J.; Chassin, L.; MacKinnon, D. P. (2000). “Home smoking restrictions and adolescent smoking”. Nicotine & Tobacco Research. 2 (2): 159–167. doi:10.1080/713688125. PMID 11072454. S2CID 8749779.
  75. ^ Urberg, K.; Shyu, S. J.; Liang, J. (1990). “Peer influence in adolescent cigarette smoking”. Addictive Behaviors. 15 (3): 247–255. doi:10.1016/0306-4603(90)90067-8. PMID 2378284.
  76. ^ Bharatula, Arun (2016). Review: Tobacco outlet density. Melbourne.[permanent dead link]
  77. ^ Michell L, West P (1996). “Peer pressure to smoke: the meaning depends on the method”. Health Education Research. 11 (1): 39–49. doi:10.1093/her/11.1.39.
  78. ^ Barber, J.; Bolitho, F.; Bertrand, L. (1999). “The Predictors of Adolescent Smoking”. Journal of Social Service Research. 26 (1): 51–66. doi:10.1300/J079v26n01_03.
  79. ^ Pelosi, Anthony J. (2019). “Personality and fatal diseases: Revisiting a scientific scandal”. Journal of Health Psychology. 24 (4): 421–439. doi:10.1177/1359105318822045. ISSN 1359-1053. PMC 6712909. PMID 30791726.
  80. ^ “King’s College London enquiry into publications authored by Professor Hans Eysenck with Professor Ronald Grossarth-Maticek” (PDF). October 2019. Archived (PDF) from the original on 5 November 2022. Retrieved 13 January 2020.
  81. ^ Nigel Hawkes (2019), Works by eminent psychologist who doubted smoking caused cancer are “unsafe,” finds inquiry Archived 4 January 2023 at the Wayback Machine
  82. ^ Eysenck, Hans J.; Brody, Stuart (November 2000). Smoking, health and personality. Transaction. ISBN 978-0-7658-0639-0.
  83. ^ Berlin, I.; Singleton, E. G.; Pedarriosse, A. M.; Lancrenon, S.; Rames, A.; Aubin, H. J.; Niaura, R. (2003). “The Modified Reasons for Smoking Scale: factorial structure, gender effects and relationship with nicotine dependence and smoking cessation in French smokers”. Addiction. 98 (11): 1575–1583. doi:10.1046/j.1360-0443.2003.00523.x. PMID 14616184.
  84. ^ “Nicotine”. Imperial College London. Archived from the original on 14 July 2009. Retrieved 22 March 2009. {{cite journal}}: Cite journal requires |journal= (help)
  85. ^ Chandra, S.; Chaloupka, F. J. (2003). “Seasonality in cigarette sales: patterns and implications for tobacco control”. Tobacco Control. 12 (1): 105–107. doi:10.1136/tc.12.1.105. PMC 1759100. PMID 12612375.
  86. ^ Chandra, S.; Shiffman, S.; Scharf, M.; Dang, Q.; Shadel, G. (February 2007). “Daily smoking patterns, their determinants, and implications for quitting”. Experimental and Clinical Psychopharmacology. 15 (1): 67–80. doi:10.1037/1064-1297.15.1.67. ISSN 1064-1297. PMID 17295586.
  87. ^ Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson; Mitchell, Richard (18 May 2007). “Chapter 8: Environmental and Nutritional Diseases”. Robbins Basic Pathology (8th ed.). Philadelphia: W.B. Saunders. p. 288, Figure 8–6. ISBN 978-1-4160-2973-1.
  88. ^ Jump up to:a b Kalkhoran, S; Benowitz, NL; Rigotti, AN (August 2018). “Prevention and Treatment of Tobacco Use: JACC Health Promotion Series”. Journal of the American College of Cardiology. 72 (9). Elsevier for the American College of Cardiology: 1030–45. doi:10.1016/j.jacc.2018.06.036. ISSN 1558-3597. PMC 6261256. PMID 30139432. S2CID 52077567. Archived from the original on 9 August 2020. Retrieved 1 August 2020.
  89. ^ “ASH > Action on Smoking & Health”. www.ash.org. 2 August 2012. Archived from the original on 19 November 2016. Retrieved 16 November 2016.
  90. ^ Jump up to:a b c Rodu, B; Plurphanswat, N (January 2021). “Mortality among male cigar and cigarette smokers in the USA” (PDF). Harm Reduction Journal. 18 (7). BioMed Central: 7. doi:10.1186/s12954-020-00446-4. ISSN 1477-7517. LCCN 2004243422. PMC 7789747. PMID 33413424. S2CID 230800394. Archived (PDF) from the original on 26 August 2021. Retrieved 28 August 2021.
  91. ^ Nonnemaker, J; Rostron, B; Hall, P; MacMonegle, A; Apelberg, B (September 2014). Morabia, A (ed.). “Mortality and Economic Costs From Regular Cigar Use in the United States, 2010”. American Journal of Public Health. 104 (9). American Public Health Association: e86 – e91. doi:10.2105/AJPH.2014.301991. eISSN 1541-0048. ISSN 0090-0036. PMC 4151956. PMID 25033140. S2CID 207276270.
  92. ^ Shah, RS; Cole, JW (July 2010). “Smoking and stroke: the more you smoke the more you stroke”. Expert Review of Cardiovascular Therapy. 8 (7). Informa: 917–932. doi:10.1586/erc.10.56. ISSN 1744-8344. PMC 2928253. PMID 20602553. S2CID 207215548.
  93. ^ Jump up to:a b Laniado-Laborín, Rafael (January 2009). “Smoking and Chronic Obstructive Pulmonary Disease (COPD). Parallel Epidemics of the 21st Century”. International Journal of Environmental Research and Public Health. 6 (1: Smoking and Tobacco Control). MDPI: 209–224. doi:10.3390/ijerph6010209. ISSN 1660-4601. PMC 2672326. PMID 19440278. S2CID 19615031.
  94. ^ Oh, CK; Murray, LA; Molfino, NL (February 2012). “Smoking and Idiopathic Pulmonary Fibrosis”. Pulmonary Medicine. 2012. Hindawi Publishing Corporation: 808260. doi:10.1155/2012/808260. ISSN 2090-1844. PMC 3289849. PMID 22448328. S2CID 14090263.
  95. ^ Jump up to:a b c Thun, Michael J.; Jacobs, Eric J.; Shapiro, Jean A. (February 2000). Ganz, Patricia A. (ed.). “Cigar Smoking in Men and Risk of Death From Tobacco-Related Cancers”. Journal of the National Cancer Institute. 92 (4). Oxford University Press: 333–337. doi:10.1093/jnci/92.4.333. eISSN 1460-2105. ISSN 0027-8874. PMID 10675383. S2CID 7772405. Archived from the original on 21 April 2021. Retrieved 28 August 2021.
  96. ^ Jump up to:a b c Anjum F, Zohaib J (4 December 2020). “Oropharyngeal Squamous Cell Carcinoma”. Definitions (Updated ed.). Treasure Island (FL): StatPearls Publishing. doi:10.32388/G6TG1L. PMID 33085415. S2CID 229252540. Bookshelf ID: NBK563268. Archived from the original on 11 June 2021. Retrieved 7 February 2021 – via NCBI.
  97. ^ Gormley, Mark; Creaney, Grant; Schache, Andrew; Ingarfield, Kate; Conway, David I. (11 November 2022). “Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors”. British Dental Journal. 233 (9): 780–786. doi:10.1038/s41415-022-5166-x. ISSN 0007-0610. PMC 9652141. PMID 36369568.
  98. ^ Hashibe, Mia; Brennan, Paul; Chuang, Shu-chun; Boccia, Stefania; Castellsague, Xavier; Chen, Chu; Curado, Maria Paula; Dal Maso, Luigino; Daudt, Alexander W.; Fabianova, Eleonora; Fernandez, Leticia; Wünsch-Filho, Victor; Franceschi, Silvia; Hayes, Richard B.; Herrero, Rolando (1 February 2009). “Interaction between Tobacco and Alcohol Use and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium”. Cancer Epidemiology, Biomarkers & Prevention. 18 (2): 541–550. doi:10.1158/1055-9965.EPI-08-0347. ISSN 1055-9965. PMC 3051410. PMID 19190158.
  99. ^ Inflamm Bowel Dis. May 2009, P. Seksik, I Nion-Larmurier
  100. ^ Rom O, Kaisari S, Aizenbud D, Reznick AZ (2013). “Cigarette smoke and muscle catabolism in C2 myotubes”. Mech Ageing Dev. 134 (1–2): 24–34. doi:10.1016/j.mad.2012.11.004. PMID 23262287. S2CID 322153.
  101. ^ Jump up to:a b Etemadi, Arash; Blount, Benjamin C.; Calafat, Antonia M.; Chang, Cindy M.; De Jesus, Victor R.; Poustchi, Hossein; Wang, Lanqing; Pourshams, Akram; Shakeri, Ramin; Shiels, Meredith S.; Inoue-Choi, Maki; Ambrose, Bridget K.; Christensen, Carol H.; Wang, Baoguang; Ye, Xiaoyun; Murphy, Gwen; Feng, Jun; Xia, Baoyun; Sosnoff, Connie S.; Boffetta, Paolo; Brennan, Paul; Bhandari, Deepak; Kamangar, Farin; Dawsey, Sanford M.; Abnet, Christian C.; Freedman, Neal D.; Malekzadeh, Reza (February 2019). “Urinary Biomarkers of Carcinogenic Exposure among Cigarette, Waterpipe, and Smokeless Tobacco Users and Never Users of Tobacco in the Golestan Cohort Study”. Cancer Epidemiology, Biomarkers & Prevention. 28 (2). American Association for Cancer Research: 337–347. doi:10.1158/1055-9965.EPI-18-0743. eISSN 1538-7755. ISSN 1055-9965. PMC 6935158. PMID 30622099. S2CID 58560832.
  102. ^ Dreyer, L et al. (1997) Tobacco Smoking. APMIS Inc.
  103. ^ Chang, Cindy M.; Corey, Catherine G.; Rostron, Brian L.; Apelberg, Benjamin J. (April 2015). “Systematic review of cigar smoking and all-cause and smoking-related mortality” (PDF). BMC Public Health. 15 (390). BioMed Central: 390. doi:10.1186/s12889-015-1617-5. ISSN 1471-2458. PMC 4408600. PMID 25907101. S2CID 16482278. Archived (PDF) from the original on 16 March 2021. Retrieved 5 September 2021.
  104. ^ Albandar, Jasim M.; Adensaya, Margo R.; Streckfus, Charles F.; Winn, Deborah M. (December 2000). “Cigar, Pipe, and Cigarette Smoking as Risk Factors for Periodontal Disease and Tooth Loss”. Journal of Periodontology. 71 (12). American Academy of Periodontology: 1874–1881. doi:10.1902/jop.2000.71.12.1874. ISSN 0022-3492. PMID 11156044. S2CID 11598500.
  105. ^ Kastan MB (2008). “DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes Memorial Award Lecture”. Mol. Cancer Res. 6 (4): 517–24. doi:10.1158/1541-7786.MCR-08-0020. PMID 18403632.
  106. ^ Liu XY, Zhu MX, Xie JP (2010). “Mutagenicity of acrolein and acrolein-induced DNA adducts”. Toxicol. Mech. Methods. 20 (1): 36–44. doi:10.3109/15376510903530845. PMID 20158384. S2CID 8812192.
  107. ^ Speit G, Merk O (2002). “Evaluation of mutagenic effects of formaldehyde in vitro: detection of crosslinks and mutations in mouse lymphoma cells”. Mutagenesis. 17 (3): 183–7. doi:10.1093/mutage/17.3.183. PMID 11971987.
  108. ^ Pu X, Kamendulis LM, Klaunig JE (2009). “Acrylonitrile-induced oxidative stress and oxidative DNA damage in male Sprague-Dawley rats”. Toxicol. Sci. 111 (1): 64–71. doi:10.1093/toxsci/kfp133. PMC 2726299. PMID 19546159.
  109. ^ Koturbash I, Scherhag A, Sorrentino J, Sexton K, Bodnar W, Swenberg JA, Beland FA, Pardo-Manuel Devillena F, Rusyn I, Pogribny IP (2011). “Epigenetic mechanisms of mouse interstrain variability in genotoxicity of the environmental toxicant 1,3-butadiene”. Toxicol. Sci. 122 (2): 448–56. doi:10.1093/toxsci/kfr133. PMC 3155089. PMID 21602187.
  110. ^ Garcia CC, Angeli JP, Freitas FP, Gomes OF, de Oliveira TF, Loureiro AP, Di Mascio P, Medeiros MH (2011). “[13C2]-Acetaldehyde promotes unequivocal formation of 1,N2-propano-2′-deoxyguanosine in human cells”. J. Am. Chem. Soc. 133 (24): 9140–3. doi:10.1021/ja2004686. PMID 21604744. Archived from the original on 6 November 2020. Retrieved 1 December 2019.
  111. ^ Tompkins EM, McLuckie KI, Jones DJ, Farmer PB, Brown K (2009). “Mutagenicity of DNA adducts derived from ethylene oxide exposure in the pSP189 shuttle vector replicated in human Ad293 cells”. Mutat. Res. 678 (2): 129–37. Bibcode:2009MRGTE.678..129T. doi:10.1016/j.mrgentox.2009.05.011. PMID 19477295.
  112. ^ Fabiani R, Rosignoli P, De Bartolomeo A, Fuccelli R, Morozzi G (2007). “DNA-damaging ability of isoprene and isoprene mono-epoxide (EPOX I) in human cells evaluated with the comet assay”. Mutat. Res. 629 (1): 7–13. Bibcode:2007MRGTE.629….7F. doi:10.1016/j.mrgentox.2006.12.007. PMID 17317274.
  113. ^ Alarabi, A. B.; Karim, Z. A.; Alshbool, F. Z.; Khasawneh, F. T.; Hernandez, Keziah R.; Lozano, Patricia A.; Montes Ramirez, Jean E.; Rivera, José O. (February 2020). “Short-Term Exposure to Waterpipe/Hookah Smoke Triggers a Hyperactive Platelet Activation State and Increases the Risk of Thrombogenesis”. Arteriosclerosis, Thrombosis, and Vascular Biology. 40 (2). Lippincott Williams & Wilkins: 335–349. doi:10.1161/ATVBAHA.119.313435. ISSN 1079-5642. PMC 7000176. PMID 31941383. S2CID 210335103.
  114. ^ Patel, Mit P.; Khangoora, Vikramjit S.; Marik, Paul E. (October 2019). “A Review of the Pulmonary and Health Impacts of Hookah Use”. Annals of the American Thoracic Society. 16 (10). American Thoracic Society: 1215–1219. doi:10.1513/AnnalsATS.201902-129CME. ISSN 2325-6621. PMID 31091965. S2CID 155103502.
  115. ^ Qasim, Hanan; Alarabi, A. B.; Alzoubi, K. H.; Karim, Z. A.; Alshbool, F. Z.; Khasawneh, F. T. (September 2019). “The effects of hookah/waterpipe smoking on general health and the cardiovascular system” (PDF). Environmental Health and Preventive Medicine. 24 (58). BioMed Central: 58. Bibcode:2019EHPM…24…58Q. doi:10.1186/s12199-019-0811-y. ISSN 1347-4715. PMC 6745078. PMID 31521105. S2CID 202570973. Archived (PDF) from the original on 24 April 2021. Retrieved 8 September 2021.
  116. ^ Jump up to:a b Farag, Mohamed A.; Elmassry, Moamen M.; El-Ahmady, Sherweit H. (19 November 2018). “The characterization of flavored hookahs aroma profile and in response to heating as analyzed via headspace solid-phase microextraction (SPME) and chemometrics”. Scientific Reports. 8 (1): 17028. Bibcode:2018NatSR…817028F. doi:10.1038/s41598-018-35368-6. ISSN 2045-2322. PMC 6242864. PMID 30451904.
  117. ^ WHO Report on the Global Tobacco Epidemic, 2008
  118. ^ “Nicotine: A Powerful Addiction Archived 1 May 2009 at the Wayback Machine.” Centers for Disease Control and Prevention.
  119. ^ Jump up to:a b Barendregt J. J., Bonneux L., van der Maas P. J. (1997). “The health care costs of smoking” (PDF). New England Journal of Medicine. 337 (15): 1052–1057. doi:10.1056/NEJM199710093371506. hdl:1765/59780. PMID 9321534. Archived (PDF) from the original on 8 October 2022. Retrieved 20 April 2018.
  120. ^ Peto Richard; Darby Sarah; Deo Harz; et al. (2000). “Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies”. The BMJ. 321 (7257): 323–329. doi:10.1136/bmj.321.7257.323. PMC 27446. PMID 10926586.
  121. ^ Yoshida, Kenichi; Gowers, Kate H. C.; Lee-Six, Henry; Chandrasekharan, Deepak P.; Coorens, Tim; Maughan, Elizabeth F.; Beal, Kathryn; Menzies, Andrew; Millar, Fraser R.; Anderson, Elizabeth; Clarke, Sarah E.; Pennycuick, Adam; Thakrar, Ricky M.; Butler, Colin R.; Kakiuchi, Nobuyuki; Hirano, Tomonori; Hynds, Robert E.; Stratton, Michael R.; Martincorena, Iñigo; Janes, Sam M.; Campbell, Peter J. (2020). “Tobacco smoking and somatic mutations in human bronchial epithelium”. Nature. 578 (7794): 266–272. Bibcode:2020Natur.578..266Y. doi:10.1038/s41586-020-1961-1. PMC 7021511. PMID 31996850. Archived from the original on 12 August 2021. Retrieved 30 January 2020.
  122. ^ “Cigarette Smoking Among Adults — United States, 2006”. Archived from the original on 16 August 2019. Retrieved 29 February 2016.
  123. ^ “WHO Western Pacific | World Health Organization”. www.who.int. Archived from the original on 8 November 2009.
  124. ^ Pintarelli G, Noci S, Maspero D, Pettinicchio A, Dugo M, De Cecco L, Incarbone M, Tosi D, Santambrogio L, Dragani TA, Colombo F (September 2019). “Cigarette smoke alters the transcriptome of non-involved lung tissue in lung adenocarcinoma patients”. Scientific Reports. 9 (1): 13039. Bibcode:2019NatSR…913039P. doi:10.1038/s41598-019-49648-2. PMC 6736939. PMID 31506599.
  125. ^ Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries Archived 29 November 2010 at the Wayback Machine 26 November 2010
  126. ^ Gurillo, Pedro; Jauhar, Sameer; Murray, Robin M; MacCabe, James H (July 2015). “Does tobacco use cause psychosis? Systematic review and meta-analysis”. The Lancet Psychiatry. 2 (8): 718–725. doi:10.1016/S2215-0366(15)00152-2. PMC 4698800. PMID 26249303.
  127. ^ Nicolosi Alfredo; et al. (2003). “Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction”. Urology. 61 (1): 201–206. doi:10.1016/s0090-4295(02)02102-7. PMID 12559296. Archived from the original on 8 March 2021. Retrieved 16 July 2019.
  128. ^ Ma C, Liu Y, Neumann S, Gao X (2017). “Nicotine from cigarette smoking and diet and Parkinson disease: a review”. Translational Neurodegeneration. 6: 18. doi:10.1186/s40035-017-0090-8. PMC 5494127. PMID 28680589.
  129. ^ Dorsey ER, Sherer T, Okun MS, Bloem BR (2018). “The Emerging Evidence of the Parkinson Pandemic”. J Parkinsons Dis (Review). 8 (s1): S3–8. doi:10.3233/JPD-181474. PMC 6311367. PMID 30584159.
  130. ^ Jump up to:a b “Cigarettes Cost U.S. $7 Per Pack Sold, Study Says”. The New York Times. 12 April 2002. Archived from the original on 13 February 2008. Retrieved 29 February 2016.
  131. ^ Jump up to:a b “USATODAY.com – Study: Cigarettes cost families, society $41 per pack”. USA Today. Archived from the original on 24 May 2011. Retrieved 29 February 2016.
  132. ^ Armour, Brian S.; Pitts, M. Melinda (2007). “Smoking: Taxing Health and Social Security” (PDF). www.frbatlanta.org. Federal Reserve Bank of Atlanta. Archived from the original (PDF) on 19 October 2012. Retrieved 20 May 2023.
  133. ^ “Even One Is Too Much: The Economic Consequences of Being a Smoker, Federal Reserve Bank of Atlanta, January 2013″ (PDF). Archived from the original (PDF) on 26 November 2013. Retrieved 11 July 2013.
  134. ^ “Costs and Expenditures”. Smoking and Tobacco. Centers for Disease Control and Prevention. Web. 20 January 2013. https://www.cdc.gov/tobacco/data_statistics/fact_sheets/fast_facts/ Archived 25 September 2011 at the Wayback Machine
  135. ^ Jump up to:a b “Public Finance Balance of Smoking in the Czech Republic”. Archived from the original on 19 July 2006.
  136. ^ “Snuff the Facts”. Archived from the original on 20 December 2006.
  137. ^ “Global Effects of Smoking, of Quitting, and of Taxing Tobacco” (PDF). Archived (PDF) from the original on 27 November 2021. Retrieved 2 May 2018.
  138. ^ Mostafa RM. Dilemma of women’s passive smoking. Ann Thorac Med [serial online] 2011 [cited 2011 Mar 29];6:55-6. Available from: http://www.thoracicmedicine.org/text.asp?2011/6/2/55/78410 Archived 2 June 2018 at the Wayback Machine
  139. ^ Church of Jesus Christ of Latter-day Saints (2009). “Obey the Word of Wisdom”. Basic Beliefs – The Commandments. Archived from the original on 4 September 2015. Retrieved 15 October 2009.
  140. ^ “Why is smoking not strictly forbidden in Islam?”. Archived from the original on 3 May 2014. Retrieved 2 May 2014.
  141. ^ Smith, Peter (2000). “smoking”. A concise encyclopedia of the Bahá’í Faith. Oxford: Oneworld Publications. pp. 323. ISBN 978-1-85168-184-6.
  142. ^ “WHO | Updated status of the WHO Framework Convention on Tobacco Control”. 17 November 2004. Archived from the original on 17 November 2004. Retrieved 12 December 2021.
  143. ^ “Archived copy” (PDF). www.who.int. Archived from the original (PDF) on 12 December 2019. Retrieved 15 January 2022.
  144. ^ “26, 2004-smoking-costs_x.htm Study: Cigarettes cost families, society $41 per pack”. USA Today.
  145. ^ “Reducing Tobacco Use”. Archived from the original on 21 February 2016. Retrieved 29 February 2016.
  146. ^ Hyland, A.; Bauer, J. E.; Li, Q.; Abrams, S. M.; Higbee, C.; Peppone, L.; Cummings, K. M. (2005). “Higher cigarette prices influence cigarette purchase patterns”. Tobacco Control. 14 (2): 86–92. doi:10.1136/tc.2004.008730. PMC 1748009. PMID 15791017.
  147. ^ Nargis, Nigar; Stoklosa, Michal; Shang, Ce; Drope, Jeffrey (January 2021). “Price, Income, and Affordability as the Determinants of Tobacco Consumption: A Practitioner’s Guide to Tobacco Taxation”. Nicotine & Tobacco Research. 23 (1): 40–47. doi:10.1093/ntr/ntaa134. PMC 7789936. PMID 32697827. Retrieved 18 September 2024.
  148. ^ “TTB – Tax Audit Division – Tax and Fee Rates”. Archived from the original on 26 February 2016. Retrieved 29 February 2016.
  149. ^ Helen C. Alvarez (28 March 2014). “You and Cigarettes”. Archived from the original on 4 March 2016. Retrieved 29 February 2016.
  150. ^ “Tax on shopping and services”. GOV.UK. Archived from the original on 24 November 2022. Retrieved 1 April 2023.
  151. ^ “Tobacco Smuggling & Crossborder Shopping ” Tobacco Manufacturers’ Association”. Archived from the original on 8 September 2008. Retrieved 29 February 2016.
  152. ^ Scollo, Michelle (2008). “13.2 Tobacco taxes in Australia” Archived 24 October 2022 at the Wayback Machine. Tobacco in Australia. Cancer Council Victoria. Retrieved 29 July 2010.
  153. ^ “History of Tobacco Regulation*”. Archived from the original on 16 June 2010. Retrieved 29 February 2016.
  154. ^ “Phil Taylor’s Papers ” Index”. Archived from the original on 12 February 2012. Retrieved 29 February 2016.
  155. ^  European Union – Tobacco advertising ban takes effect July 31  Archived 24 January 2011 at the Wayback Machine
  156. ^ “Report on the implementation of the EU Tobacco Advertising Directive” (PDF). Archived (PDF) from the original on 5 September 2011. Retrieved 4 August 2008.
  157. ^ Tobacco – Health warnings Australian Government Department of Health and Ageing. Retrieved 29 August 2008
  158. ^ Public Health at a Glance – Tobacco Pack Information
  159. ^ Scottish Government, St Andrew’s House (21 January 2013). “Tobacco Display Ban Guidance”. www2.gov.scot. Archived from the original on 27 November 2019. Retrieved 27 November 2019.
  160. ^ “Guidance on the display and pricing of tobacco products in Northern Ireland | Department of Health”. Health. 25 August 2015. Archived from the original on 27 November 2019. Retrieved 27 November 2019.
  161. ^ Norwegian Government (1996). “Act No. 14 of March 9th, 1973 Relating to Prevention of the Harmful Effects of Tobacco (The Tobacco Control Act)” (PDF). Archived from the original (PDF) on 18 March 2017. Retrieved 27 November 2019.
  162. ^ “WHO | Norway: Prohibition on the visible display of tobacco products at the points of sale”. WHO. Archived from the original on 13 February 2020. Retrieved 27 November 2019.
  163. ^ “Imperial Tobacco take fight against cigarette display ban to Supreme”. The Independent. 12 November 2012. Archived from the original on 21 June 2022. Retrieved 27 November 2019.
  164. ^ Carrell, Severin; correspondent, Scotland (12 December 2012). “Scotland to ban cigarette displays in shops after court challenge fails”. The Guardian. ISSN 0261-3077. Archived from the original on 27 November 2019. Retrieved 27 November 2019. {{cite news}}: |last2= has generic name (help)
  165. ^ World Health Organization (2017). “Evidence brief: Tobacco point-of-sale display bans” (PDF). WHO. Archived from the original (PDF) on 27 November 2019. Retrieved 27 November 2019.
  166. ^ “Tobacco Sales Law”. Archived from the original on 23 November 2010. Retrieved 29 February 2016.
  167. ^ Ahlfeldt, G., Maennig, W. (2010), Impact of non-smoking ordinances on hospitality revenues: The case of Germany, in Journal of Economics and Statistics, 230(5), 506–521; preliminary version in: Hamburg Contemporary Discussion Papers N° 26, http://www.uni-hamburg.de/economicpolicy/hced.html Archived 23 May 2016 at the Wayback Machine.
  168. ^ “NFPA applauds Reynolds American Inc”. Archived from the original on 1 March 2013. Retrieved 29 February 2016.
  169. ^ “NFPA” (PDF). Archived from the original (PDF) on 20 November 2007. Retrieved 29 February 2016.
  170. ^ Jump up to:a b “Coalition for Fire-Safe Cigarettes”. Archived from the original on 16 August 2011. Retrieved 29 February 2016.
  171. ^ Lindeman, Tracey (1 August 2023). “‘Poison in every puff’: Canada puts health warnings on individual cigarettes”. The Guardian. ISSN 0261-3077. Retrieved 8 August 2023.
  172. ^ C. Merrill, J.; Kleber, H. D.; Shwartz, M.; Liu, H.; Lewis, S. R. (1999). “Cigarettes, alcohol, marijuana, other risk behaviors, and American youth”. Drug and Alcohol Dependence. 56 (3): 205–212. doi:10.1016/S0376-8716(99)00034-4. PMID 10529022.
  173. ^ Swan, G. C.; Carmelli, D.; Rosenman, R. H.; Fabsitz, R. R.; Christian, J. C. (1990). “Smoking and alcohol consumption in adult male twins: genetic heritability and shared environmental influences” (Free full text). Journal of Substance Abuse. 2 (1): 39–50. doi:10.1016/S0899-3289(05)80044-6. ISSN 0899-3289. PMID 2136102. Archived from the original on 4 July 2016. Retrieved 7 April 2016.
  174. ^ “Why Nicotine is a Gateway Drug”. National Institutes of Health (NIH). 22 May 2015. Archived from the original on 11 April 2020. Retrieved 20 April 2020.
  175. ^ Rohsenow, Damaris J.; Martin, Rosemarie A.; Tidey, Jennifer W.; Colby, Suzanne M.; Monti, Peter M. (2017). “Treating Smokers in Substance Treatment With Contingent Vouchers, Nicotine Replacement and Brief Advice Adapted for Sobriety Settings”. Journal of Substance Abuse Treatment. 72: 72–79. doi:10.1016/j.jsat.2016.08.012. PMC 5154824. PMID 27658756.
  176. ^ “Vaping to quit smoking – NHS”. nhs.uk. 20 September 2022. Archived from the original on 21 June 2023. Retrieved 13 June 2023.
  177. ^ Tang, Yi-Yuan; Tang, Rongxiang; Posner, Michael I. (2016). “Mindfulness meditation improves emotion regulation and reduces drug abuse”. Drug and Alcohol Dependence. 163: S13 – S18. doi:10.1016/j.drugalcdep.2015.11.041. PMID 27306725.
  178. ^ Centers for Disease Control Prevention (CDC) (November 2011). “Quitting smoking among adults—United States, 2001–2010”. MMWR. Morbidity and Mortality Weekly Report. 60 (44): 1513–9. PMID 22071589. Archived from the original on 3 January 2023. Retrieved 9 May 2015.
  179. ^ Brunetta PG, Kroon L (2022). “Smoking Cessation”. In Broaddus C, Ernst JD, King, TE, et al. (eds.). Murray & Nadel’s Textbook of Respiratory Medicine (7 ed.). Elsevier. pp. 900–909.
  180. ^ Rosen, Laura J.; Galili, Tal; Kott, Jeffrey; Goodman, Mark; Freedman, Laurence S. (January 2018). “Diminishing benefit of smoking cessation medications during the first year: a meta-analysis of randomized controlled trials”. Addiction. 113 (5). Wiley-Blackwell on behalf of the Society for the Study of Addiction: 805–816. doi:10.1111/add.14134. ISSN 0965-2140. PMC 5947828. PMID 29377409. S2CID 4764039.
  181. ^ “Family First: Dr. Anil’s Love-Infused Anti-Smoking Initiative”. GorakhaPatra. Retrieved 5 February 2024.

Recommended HashTags

Leave a Comment

Your email address will not be published. Required fields are marked *

Translate »